pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Abiraterone Acetate Patriot
drug · small molecule
save

abiraterone acetate

Phase 3updated 3mo ago
by Tavanta Therapeutics Inc🔗 ChEMBL
Phase 3
community read0 votes

🐶 often sniffed alongside

top 6
  • tagApproval4 co-mentions · 2 sources
  • drugAKEEGA4 co-mentions · 2 sources
  • companyJanssen Biotech Inc2 co-mentions · 2 sources
  • tagSmall Molecule2 co-mentions · 2 sources
  • drug(abiraterone acetate + niraparib)2 co-mentions · 2 sources
  • drugYonsa2 co-mentions · 2 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 9 investigational indications.

targets

Steroid 17-alpha-hydroxylase/17,20 lyase

all catalysts(0)

nothing on the calendar yet

Trials studying abiraterone acetate

  • phase2A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladderactive not recruitingn=12
  • phase3A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancerrecruitingn=750
  • —Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Canceractive not recruitingn=3,000
  • phase2Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Canceractive not recruitingn=7
  • phase2A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancerrecruitingn=218
  • phase1A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Canceractive not recruitingn=136
  • phase1A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Canceractive not recruitingn=57
  • phase1M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)active not recruitingn=60
more trials →

News(2)

  • REVELUTION-2 Trial Is Evaluating Cardiovascular Risk With Relugolix Plus Abiraterone Acetate in High-Risk Prostate Cancer
    Sagar A. Patel, MD, discusses the REVELUTION-2 trial evaluating cardiovascular safety with hormone therapy in prostate cancer.
    onclive · 2mo ago
  • GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
    We spoke with leading voices in GU oncology to see which presentations they are most looking forward to during the 2026 ASCO Annual Meeting.
    onclive · 3mo ago
brand
Abiraterone Acetate Patriot
trade names
Abiraterone accord, Abiraterone acetate component of akeega, Abiraterone krka, Abiraterone mylan, Yonsa, Zytiga
generic
abiraterone acetate
MOA
Cytochrome P450 17A1 inhibitor
indication
Hormone-Sensitive Prostate Cancer
phase
phase_3
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?